1
Clinical Trials associated with [18F]-JNJ-70099731An Open-Label Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand [18F]-JNJ-70099731 in Healthy Male Participants
The purposes of this study are to measure the whole-body distribution and radiation dosimetry of [18F]-JNJ-70099731 (Part A), to measure the uptake, distribution, and clearance (CL) of [18F]-JNJ-70099731 by Positron Emission Tomography (PET) and to model tissue specific kinetics of [18F]-JNJ-70099731 with the appropriate input function (IF) (Part B), and to measure participant test-retest variability in the distribution of [18F]-JNJ-70099731 by comparing PET scans obtained at least 1 week apart (Part C) in the brain of healthy male participants.
100 Clinical Results associated with [18F]-JNJ-70099731
100 Translational Medicine associated with [18F]-JNJ-70099731
100 Patents (Medical) associated with [18F]-JNJ-70099731
100 Deals associated with [18F]-JNJ-70099731